Berlin - Delayed Quote EUR

Enochian BioSciences Inc (2Q5.BE)

Compare
0.8480
-0.1260
(-12.94%)
At close: January 24 at 9:52:07 PM GMT+1
All numbers in thousands
Breakdown
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Assets
163,129.4500
58,300.7960
84,632.6630
189,605.2250
Total Liabilities Net Minority Interest
31,152.3060
11,798.6850
12,013.8150
14,942.2860
Total Equity Gross Minority Interest
131,977.1440
46,502.1110
72,618.8480
174,662.9390
Total Capitalization
131,977.1440
46,502.1110
77,195.9960
180,442.0530
Common Stock Equity
131,977.1440
46,502.1110
72,618.8480
174,662.9390
Capital Lease Obligations
1,335.9420
969.0090
1,239.3350
1,531.7430
Net Tangible Assets
-27,383.0600
-7,788.5650
-636.4200
8,133.0330
Working Capital
-28,312.2740
-8,457.6930
3,114.1700
19,013.1000
Invested Capital
134,428.1400
51,127.0580
78,395.9960
180,442.0530
Tangible Book Value
-27,383.0600
-7,788.5650
-636.4200
8,133.0330
Total Debt
3,786.9380
5,593.9560
7,016.4830
7,310.8570
Net Debt
2,230.5290
2,750.4670
--
--
Share Issued
155,027.2450
63,698.1440
53,007.0820
52,219.6610
Ordinary Shares Number
155,027.2450
63,698.1440
53,007.0820
52,219.6610
6/30/2021 - 6/10/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers